|By PR Newswire||
|February 20, 2014 02:00 AM EST||
NORTH CHICAGO, Ill., Feb. 20, 2014 /PRNewswire/ -- AbbVie today announced the launch of 'Perspectives – Art, Inflammation and Me', an initiative designed to add a different dimension to the current understanding of immune-mediated inflammatory diseases (IMIDs) and their impact on patients and society. More than 100 unique artistic expressions from the initiative are being debuted at the 9th Congress of the European Crohn's and Colitis Organisation (ECCO) in Copenhagen, Denmark from February 20th to 22nd.
"Art is a well-established medium to help educate," said Jose Miralles, Perspectives judge and professor, Facultad de Belles Arts de Valencia, Universitat Politecnica de Valencia, Spain. "The artistic expressions created through Perspectives vividly bring to life the stories, dreams and challenges of patients living with inflammatory diseases. We hope people can experience the gallery and learn something new about these conditions."
IMIDs are a group of progressive and potentially debilitating conditions that can affect various parts of the body such as the joints (rheumatoid arthritis), the bowels (Crohn's disease), the skin (psoriasis) and the spine (ankylosing spondylitis). IMIDs can have a serious and damaging impact on the day-to-day lives of those affected, and those around them.
More than 200 unique artistic expressions – all inspired by collaborations between artists and patients – provide new and different perspectives into some of the unknown, ignored or often underestimated burdens associated with some of these conditions. The initiative involves more than 200 artists from more than 40 countries around the world. In addition to professional and independent artists, Perspectives included art students from more than 15 universities in France, Canada, Italy and Spain through collaborations with the Polytechnic University of Valencia (Universitat Politecnica de Valencia).
The artistic expressions include but are not limited to sculptures, photographs, paintings and installations. Perspectives will visit various art galleries and medical conferences throughout the world, with additional exhibition dates and locations to be announced later this year.
"The stories and artworks in Perspectives may contribute to the current understanding of these diseases and their impact on patients and society from a very personal and emotional point of view," said Isidro Villanueva, M.D., Ph.D., group therapeutic area lead, Medical Affairs, Immunology, AbbVie. "AbbVie is a global, research-based biopharmaceutical company committed to addressing some of today's toughest health challenges. Helping others understand the impact associated with some of these chronic conditions is part of that commitment."
'Perspectives – Art, Inflammation and Me' is an initiative that brings together more than 200 artists with patients in more than 40 countries. Together, they have created a series of paintings, sculptures, photos and other artistic expressions that vividly depict — and help others understand — the impact of immune-mediated inflammatory diseases (IMIDs). Inspired by patients' stories, independent artists and students from a number of art universities created each piece to help more people better understand the burdens associated with some of these chronic and debilitating conditions. In addition to independent artists from all parts of the world, students from more than 15 universities coordinated by the Polytechnic University of Valencia (Universitat Politecnica de Valencia) were able to add their "Perspectives."
Key Perspectives artworks featured at ECCO include:
'Tic Tac Toe'– A cross-stitching artwork from the U.S., symbolic of life with Crohn's Disease (CD). Much like a game, CD is a disease through which there are personal wins, losses and draws. Words like hope, strength, endurance, courage, ache and "ow" illustrate the range of emotions experienced while on the road from awareness to diagnosis – noting that while one does not always win at the game of life or CD, one still has to play.
Artist: Barbara Miller
'Coexistentia'– A sculpture from Spain that portrays the story of a patient with Crohn's disease. The body is made of iron, representing the emotional armour that the patient constructs to protect themselves from the impact of the disease, and the intestinal area is made of marble, a hard and compact material, to symbolize the disease itself.
Artist: Guillermo Ros Lluch
'Captive?' – A photograph taken at a historic jail in Ireland that signifies the patient's feeling of entrapment, both physically and emotionally, and his sense of being 'locked up'. Framed in the doorway of a cell, the patient is neither inside the cell nor out. As with his condition, ulcerative colitis, no barriers are immediately apparent but confinements are all around.
Artist: John Minihan
Note: Full-size, high resolution images of these artworks are available upon request.
AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. AbbVie employs approximately 25,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.com. Follow @abbvie on Twitter or view careers on our Facebook or LinkedIn page.
 Kuek A, Hazleman BL and Ostor AJK. Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution. Postgrad Med J 2007; 83(978): 251-260
Big Data has been changing the world. IoT fuels the further transformation recently. How are Big Data and IoT related? In his session at @BigDataExpo, Tony Shan, a renowned visionary and thought leader, will explore the interplay of Big Data and IoT. He will anatomize Big Data and IoT separately in terms of what, which, why, where, when, who, how and how much. He will then analyze the relationship between IoT and Big Data, specifically the drilldown of how the 4Vs of Big Data (Volume, Variety,...
Sep. 26, 2016 10:00 AM EDT Reads: 996
Sep. 26, 2016 10:00 AM EDT Reads: 2,669
SYS-CON Events announced today that ReadyTalk, a leading provider of online conferencing and webinar services, has been named Vendor Presentation Sponsor at the 19th International Cloud Expo, which will take place on November 1–3, 2016, at the Santa Clara Convention Center in Santa Clara, CA. ReadyTalk delivers audio and web conferencing services that inspire collaboration and enable the Future of Work for today’s increasingly digital and mobile workforce. By combining intuitive, innovative tec...
Sep. 26, 2016 10:00 AM EDT Reads: 2,707
Sep. 26, 2016 09:45 AM EDT Reads: 2,795
Sep. 26, 2016 09:15 AM EDT Reads: 2,717
Sep. 26, 2016 09:00 AM EDT Reads: 1,061
Sep. 26, 2016 09:00 AM EDT Reads: 1,523
Sep. 26, 2016 08:30 AM EDT Reads: 2,550
Sep. 26, 2016 08:30 AM EDT Reads: 2,465
Sep. 26, 2016 08:15 AM EDT Reads: 2,448
Sep. 26, 2016 08:15 AM EDT Reads: 2,544
Sep. 26, 2016 08:15 AM EDT Reads: 1,541
Sep. 26, 2016 07:15 AM EDT Reads: 1,893
Sep. 26, 2016 07:15 AM EDT Reads: 1,601
Digitization is driving a fundamental change in society that is transforming the way businesses work with their customers, their supply chains and their people. Digital transformation leverages DevOps best practices, such as Agile Parallel Development, Continuous Delivery and Agile Operations to capitalize on opportunities and create competitive differentiation in the application economy. However, information security has been notably absent from the DevOps movement. Speed doesn’t have to negat...
Sep. 26, 2016 06:45 AM EDT Reads: 1,999